Member of the Executive Team, responsible for all elements of company operations and strategy, including financing, corporate development and partnering, financial operations, program and portfolio management, legal, and HR.- Led financing efforts, including $265M Series B financing- Led corporate development efforts, including principal sourcing and negotiation of multi-indication discovery, development, and commercialization collaboration with Regeneron, with $75M upfront, $45M in early milestones, and 50/50 cost and profit sharing structure- Built and managed Finance, Legal, HR, and Program Management functions

Led and supported incubation efforts for multiple early company concepts.

CEO and Director of Second Genome, a South San Francisco biotechnology company developing novel drugs from microbiome science. Led the company from an early team of founders to 30 employees.

Commercial roles with increasing responsibility at Ingenuity Systems, a Bay Area systems biology company.

Responsible for corporate strategy, business development, and marketing activities for publicly traded life sciences e-commerce pioneer.

Strategic consulting to clients in the pharmaceutical, biotech, medical device and diagnostic industries, focused on opportunity assessment, merger and acquisition advisory, and strategic planning.